Quantification of the co-localization analysis demonstrated a significant increase in the double-positive cells (DPCs) for NICD and CD38 (Fig. 6C, 66.2% in AAA as compared to 4% in controls (R2 = 0.61; white arrows in Fig. 6B). This evidence concerns the gene CD38 and triple-A syndrome.